Adenine / Anhydrous Citric Acid / Dextrose / Monobasic / Monohydrate / Sodium Phosphate / Trisodium
CPDA-1 (Citrate Phosphate Dextrose Adenine) is a sterile anticoagulant solution used in blood collection bag systems to preserve whole blood and blood components for transfusion use.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 3 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Adenine / Anhydrous Citric Acid / Dextrose / Monobasic / Monohydrate / Sodium Phosphate / Trisodium: Patient Information Guide
A plain-language walkthrough of Adenine / Anhydrous Citric Acid / Dextrose / Monobasic / Monohydrate / Sodium Phosphate / Trisodium — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
CPDA-1 (Citrate Phosphate Dextrose Adenine) solution is used exclusively in professional blood collection settings — not as a medication taken by patients.
- TERUFLEX Blood Anticoagulant CPDA-1 (all products): Collection, processing, and preservation of whole blood and blood components for transfusion
- TERUFLEX Blood Anticoagulant CPDA-1 for Collection of 450mL of Blood: Designed specifically for collecting 450 mL (±10%) of whole blood
- TERUFLEX BLOOD with Diversion Blood Sampling Arm 70 mL CPDA-1 and teruflex blood bag system with diversion blood sampling arm 70 ml cpda-1: Include an integral diversion pouch to collect donor blood samples for laboratory testing before the main unit is collected
- All TERUFLEX CPDA-1 products support further processing into components such as red blood cells, platelets, and plasma using standard blood bank techniques
- Not intended for direct intravenous infusion into any patient
💊How it's taken▾
These are professional-use blood collection systems, not medications dosed by patients. Trained blood bank staff use the TERUFLEX CPDA-1 bag system to collect whole blood (450 mL ±10% or 500 mL ±10% depending on the product), following institutional standard operating procedures. The anticoagulant solution inside the bag acts during and after collection to keep blood from clotting. After collection, blood components must be separated and stored according to strict time and temperature requirements — for example, red blood cells are stored at 1–6°C for up to 35 days.
🤒Side effects — in detail▾
Side effects are not listed in the FDA label for this blood collection system, as it is a professional-use device — not a drug taken by patients.
⚠️Warnings & precautions▾
- Inspect before every use: Do not use the bag if the solution is cloudy, contains particles, or if the bag shows any signs of leaking.
- Storage: Keep at room temperature (15–30°C / 59–86°F). Never expose to excessive heat, direct sunlight, or freezing temperatures.
- Infection control: Human blood carries potential infectious agents. Always follow institutional protocols to protect both donors and staff.
- Aseptic technique required: All steps must be performed using sterile methods to prevent contamination of the blood supply.
- Needle safety: Never touch the needle after removing its cover. Use approved needle safety devices.
- Dielectric tube sealer caution: Do not use one to seal tubing while the needle is still in the donor's arm unless the device is specifically cleared for that use.
- AGELESS oxygen absorber packet: This packet is inside the blister package, generates heat when opened, and should never be opened. Dispose of it with the blister tray only — not with flammable waste.
📋Before taking it▾
- This product is for use only by trained healthcare and blood bank professionals — not for patient self-use
- Requires a prescription (Rx only)
- Only use if the solution appears clear and free of particles
- Do not use if the bag set shows any leaks
- Handle the AGELESS oxygen absorber packet with care — it generates heat and should not be opened
- Follow all institutional procedures for handling human blood to prevent exposure to infectious agents
📦How to store it▾
Room Temperature (15-30°C/59-86°F). Avoid excessive heat and direct sunlight. Protect from freezing.
📄 Written from Adenine / Anhydrous Citric Acid / Dextrose / Monobasic / Monohydrate / Sodium Phosphate / Trisodium’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Adenine / Anhydrous Citric Acid / Dextrose / Monobasic / Monohydrate / Sodium Phosphate / Trisodium — the kind of thing our pharmacy team would talk through with you at the counter.
Is this something a patient takes as a medication? ▾
Why does the blood bag contain all those ingredients — citric acid, dextrose, adenine, and phosphate? ▾
What is the diversion pouch on some of the TERUFLEX bags for? ▾
How long can blood collected in a CPDA-1 bag be stored? ▾
Is there anything I need to know as a blood donor about the bag being used to collect my blood? ▾
What should blood bank staff watch out for when using these bags? ▾
Is Adenine / Anhydrous Citric Acid / Dextrose / Monobasic / Monohydrate / Sodium Phosphate / Trisodium available over the counter? ▾
When was Adenine / Anhydrous Citric Acid / Dextrose / Monobasic / Monohydrate / Sodium Phosphate / Trisodium first available? ▾
💬 Answers drafted from Adenine / Anhydrous Citric Acid / Dextrose / Monobasic / Monohydrate / Sodium Phosphate / Trisodium’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Adenine / Anhydrous Citric Acid / Dextrose / Monobasic / Monohydrate / Sodium Phosphate / Trisodium comes
Adenine / Anhydrous Citric Acid / Dextrose / Monobasic / Monohydrate / Sodium Phosphate / Trisodium is available in 1 form. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Injection
How this form is used
- TERUFLEX Blood Anticoagulant CPDA-1 products are used for the collection, processing, and preservation of whole blood and blood components
- TERUFLEX BLOOD with Diversion Blood Sampling Arm 70 mL CPDA-1 and the teruflex blood bag system with diversion blood sampling arm 70 ml cpda-1 include an integral diversion pouch to obtain donor blood samples for laboratory testing before the main collection begins
- TERUFLEX Blood Anticoagulant CPDA-1 for Collection of 450mL of Blood is designed for collection of 450 mL (±10%) of whole blood
- These products are not intended for direct intravenous infusion into a patient
- TERUFLEX CPDA-1 blood bag systems must be used following institutional standard operating procedures and aseptic technique
- TERUFLEX BLOOD with Diversion Blood Sampling Arm: close the white clamp below the diversion pouch before starting phlebotomy, and do not collect donor test samples until the tubing between the 'Y' and the diversion pouch is permanently sealed
- Mix blood with the anticoagulant solution in the collection bag continuously during and immediately after collection to prevent clotting
- Store CPDA-1 Red Blood Cells (or Whole Blood) between 1–6°C for up to 35 days after collection
📊 Adenine / Anhydrous Citric Acid / Dextrose / Monobasic / Monohydrate / Sodium Phosphate / Trisodium across the U.S. market
How Adenine / Anhydrous Citric Acid / Dextrose / Monobasic / Monohydrate / Sodium Phosphate / Trisodium appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
🔍 Compare Adenine / Anhydrous Citric Acid / Dextrose / Monobasic / Monohydrate / Sodium Phosphate / Trisodium products
A representative set of FDA-listed product records for Adenine / Anhydrous Citric Acid / Dextrose / Monobasic / Monohydrate / Sodium Phosphate / Trisodium — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Injection | ||||
| ANHYDROUS CITRIC ACID 2.99 g/1000 mL; TRISODIUM CITRATE DIHYDRATE 26.3 g/1000 mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 2.22 g/1000 mL; DEXTROSE MONOHYDRATE 31.9 g/1000 mL; ADENINE 0.275 g/1000 mL | Intravenous | Terumo Corporation × 3 listings | NDA | View NDC → |
Showing 3 of 3 products — FDA National Drug Code Directory. See every product, package size and price: browse all 3 Adenine / Anhydrous Citric Acid / Dextrose / Monobasic / Monohydrate / Sodium Phosphate / Trisodium NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Adenine / Anhydrous Citric Acid / Dextrose / Monobasic / Monohydrate / Sodium Phosphate / Trisodium — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Adenine / Anhydrous Citric Acid / Dextrose / Monobasic / Monohydrate / Sodium Phosphate / Trisodium in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Adenine / Anhydrous Citric Acid / Dextrose / Monobasic / Monohydrate / Sodium Phosphate / Trisodium went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
📦 Supply & shortage status
Whether Adenine / Anhydrous Citric Acid / Dextrose / Monobasic / Monohydrate / Sodium Phosphate / Trisodium is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 3 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Terumo Corporation is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.